Novo Nordisk

Lumos' oral growth hormone drug falls short of Novo's injectable incumbent at interim analysis
Fierce Pharma
Tue, 11/15/22 - 11:06 am
Lumos Pharma
growth hormone
Novo Nordisk
clinical trials
Early data hint at benefit for Amgen’s obesity drug
BioPharma Dive
Wed, 11/9/22 - 10:32 am
Amgen
obesity
Eli Lilly
Novo Nordisk
AMG 133
Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro
Xtalks
Thu, 11/3/22 - 07:25 pm
Eli Lilly
Mounjaro
Novo Nordisk
Ozempic
type 2 diabetes
Just announced: upcoming late-stage clinical trials in weight loss and diabetes
Clinical Trials Arena
Sun, 10/23/22 - 07:09 pm
clinical trials
Eli Lilly
Novo Nordisk
weight loss
diabetes
Ozempic
Wegovey
Mounjaro
After selling startups to Novo and Pfizer, Andera raises record €456M for latest life sciences fund
Fierce Biotech
Mon, 10/10/22 - 10:30 am
Andera Partners
funding
life sciences
startups
Pfizer
Novo Nordisk
Europe
venture capital
Lilly's tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo Nordisk's Wegovy
Fierce Pharma
Thu, 10/6/22 - 10:59 am
Eli Lilly
Novo Nordisk
obesity
FDA
fast track
tirzepatide
Novo Nordisk ready to submit once-weekly insulin to FDA after scoring final phase 3 win
Fierce Biotech
Wed, 10/5/22 - 07:11 pm
Novo Nordisk
FDA
diabetes
insulin
basal insulin
Icodec
Decades-old law keeping older adults from trying new weight loss therapies - and companies are paying millions to try to get it changed
Marketwatch
Wed, 10/5/22 - 10:46 am
Medicare
Wegovy
Novo Nordisk
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
M&A
Pfizer
Global Blood Therapeutics
Amgen
ChemoCentryx
Novo Nordisk
Forma
Alcon
Aerie Pharmaceuticals
Gilead Sciences
MiroBio
Ventus sells its lead drug candidate to Novo Nordisk
BioPharma Dive
Thu, 09/29/22 - 09:48 am
Ventus Therapeutics
Novo Nordisk
inflammatory diseases
VENT-01
Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts
Fierce Pharma
Mon, 09/26/22 - 11:25 pm
Inflation Reduction Act
Joe Biden
Novo Nordisk
Gilead Sciences
Bristol Myers Squibb
AstraZeneca
drug pricing
Novo's Once-Weekly Insulin Treatment Part of a Transforming T2D Space
BioSpace
Thu, 09/22/22 - 10:14 am
Novo Nordisk
clinical trials
type 2 diabetes
diabetes
insulin icodec
Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence
Yahoo Finance
Mon, 09/12/22 - 10:56 am
Novo Nordisk
Microsoft
drug discovery
artificial intelligence
Big Data
Zealand Pharma, Novo Nordisk Ink Licensing Pact For Diabetes Drug
Yahoo/Benzinga
Wed, 09/7/22 - 10:15 am
Zealand Pharma
Novo Nordisk
Zegalogue
diabetes
hypoglycemia
Targeting Novo Nordisk in China's obesity market with a unique proposition, LeaderMed eyes US IPO
Fierce Biotech
Fri, 09/2/22 - 12:32 pm
Novo Nordisk
obesity
China
IPOs
Novo Nordisk to acquire Forma Therapeutics in $1.1. bln deal
Yahoo/Reuters
Thu, 09/1/22 - 10:49 am
Novo Nordisk
Forma Therapeutics
M&A
blood disorders
ESC 2022 – Novo’s cardiovascular charge continues
EP Vantage
Thu, 09/1/22 - 10:13 am
ESC 2022
Novo Nordisk
ziltivekimab
PRX004
HS-001
A pharmaceutical jack of all trades? Novo CEO touts semaglutide's potential in NASH, Alzheimer's and its hot start in obesity
Fierce Pharma
Mon, 08/29/22 - 10:40 am
Novo Nordisk
semaglutide
NASH
Alzheimer's disease
Saxenda
obesity
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes
Yahoo Finance
Mon, 08/22/22 - 10:00 am
Novo Nordisk
clinical trials
CagriSema
semaglutide
diabetes
type 2 diabetes
Amid Wegovy's supply woes, Novo Nordisk sees surging demand for its original obesity drug Saxenda
Fierce Pharma
Thu, 08/4/22 - 11:05 am
Novo Nordisk
obesity
drug manufacturing
Wegovy

Pages